Stock Rich List
#567 on the corporate holders of 809 holders

Wellington Biomedical Innovation Master Investors (Cayman) II L.P.

10% owner at MBX Biosciences; 10% owner at Avalyn Pharma; 10% owner at Upstream Bio.

$134M
in disclosed stock, +$1.2M (+0.90%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
567th of 809
Companies held
3
Largest holding
MBX, 71.3% of total
Latest SEC filing
May 1, 2026

What the $134M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
MBX Biosciences MBX
Common Stock
Directly1,790,122$53.41$95.6M71.3%Form 4, Sep 16, 2024
Avalyn Pharma AVLN
Common Stock
Directly1,275,486$28.70$36.6M27.3%Form 4, May 1, 2026
Upstream Bio UPB
Common Stock
Directly894,733$2.00$1.8M1.3%Form 4, Oct 15, 2024

Share counts are the amounts Wellington Biomedical Innovation Master Investors (Cayman) II L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
564Sequoia Capital Global Growth Fund III - U.S./India Annex Fund, L.P.
10% owner, DoorDash
$136M−$8.4M (−5.80%)
565KLP 2006-N3 Family Trust
Insider, Hyatt Hotels
$135M−$5.3M (−3.76%)
566Charles F. Dolan 2009 Family Trust Fbo Marianne Dolan Weber
Insider, MSG Knickerbockers
$135M+$157K (+0.12%)
567Wellington Biomedical Innovation Master Investors (Cayman) II L.P.
10% owner, MBX Biosciences
$134M+$1.2M (+0.90%)
568Accel London Investors 2016 L.P.
10% owner, UiPath
$132M−$5.9M (−4.26%)
569CilMar Ventures, LLC Series A
10% owner, Falcon's Beyond Global
$132M−$7.9M (−5.66%)
570Idea Men, LLC
Director, GoodRx Holdings
$130M−$14.7M (−10.12%)

Other MBX Biosciences insiders

All MBX insiders

Questions

How much stock does Wellington Biomedical Innovation Master Investors (Cayman) II L.P. own?

Wellington Biomedical Innovation Master Investors (Cayman) II L.P. holds $134,006,330 in listed stock based on SEC filings and current prices, mostly MBX Biosciences (MBX). That ranks 567th on the Stock Rich List.

Is this Wellington Biomedical Innovation Master Investors (Cayman) II L.P.'s net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.